Primary-care focus crucial in tomorrow’s healthcare systems Carlene Todd Newsletter Article 09 February 2013 Pages: 3 - 5
Increased funding needed for global hep B immunisation Newsletter Article 09 February 2013 Pages: 5 - 5
Resource use lower after asthma rehabilitation programme Newsletter Article 09 February 2013 Pages: 6 - 6
Can drug formularies control antimicrobial spending? Newsletter Article 09 February 2013 Pages: 6 - 6
Direct, indirect and intangible costs of stroke in the US Newsletter Article 09 February 2013 Pages: 7 - 7
UK faces large economic burden from community-acquired LRTIs Newsletter Article 09 February 2013 Pages: 8 - 8
Fewer GI adverse events make meloxicam cost saving vs diclofenac Newsletter Article 09 February 2013 Pages: 8 - 8
Fluticasone prophylaxis favoured for children with asthma Newsletter Article 09 February 2013 Pages: 9 - 9
Cost utility of interferon-α vs hydroxycarbamide in CML Newsletter Article 09 February 2013 Pages: 9 - 9
Essential drugs list not well accepted in South Africa Newsletter Article 09 February 2013 Pages: 11 - 11
French health reforms include generic substitution Newsletter Article 09 February 2013 Pages: 12 - 12